Rare diseases
Investigational molecules
Locations
3115 Merryfield Row Suite 120, 92121-1174, United States
GB002 Inc. focuses its clinical research on pulmonary arterial hypertension, with studies centered on WHO Group 1 pulmonary hypertension and the management of disease burden in patients receiving background PAH therapy.
The sponsor’s trial portfolio reflects sustained interest in inhaled treatment approaches for PAH, including ongoing evaluation of treatment durability and clinical benefit in a multi-country research network.
GB002 Inc. runs clinical trials in conditions such as Pulmonary arterial hypertension, among others.
Clinical trials registered by this sponsor – none is enrolling right now.
Czechia
AustriaAustriaIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
